Evonik (Germany) is one of the world leaders in specialty chemicals. 80 percent of sales come from leading market positions. Evonik focuses its R&D activities and investments on high-growth megatrends, especially health, nutrition, resource efficiency and globalization. Evonik benefits specifically from its innovative process and integrated technology platforms.

In 2013 Evonik’s 33,000 employees generated sales of €12.9 billion and an operating result (adjusted EBITDA) of €2.0 billion. Evonik is active in over 100 countries around the world, and 76 percent of sales are generated outside Germany.




One comment

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s